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Abstract  
BACKGROUND: Association between vitamin D, adiponectin and obesity is a matter of debate, as 
they play important role in linking obesity with different cardio metabolic risk factors.  
AIM: Evaluation of association between metabolic risk factors with both adiponectin and 25-
Hydroxy vitamin D [25(OH) D] levels and that between adiponectin and [25(OH) D] among obese 
Egyptian children.  
SUBJECTS AND METHODS: This case-control cross sectional study consisted of 65 obese and 
30 healthy children, aged 8-11 years. 25(OH) D, serum adiponectin, total cholesterol, triglycerides, 
high-density lipoprotein-cholesterol and low-density lipoprotein-cholesterol were measured.  
RESULTS: The mean 25(OH)D and adiponectin levels in the obese were lower than that in control 
group ( <0.000). 25(OH)D were inversely correlated with body mass index, triglyceride, total 
cholesterol and LDL-cholesterol. While adiponectin level were inversely correlated with systolic and 
diastolic blood pressure, and positively correlated with high-density lipoprotein-cholesterol. 
However, there is no relation between 25(OH) D and adiponectin levels among obese children and 
total sample.  
CONCLUSION: Inspite of strong association between vitamin D and adiponectin levels with 
metabolic risk factors and obesity, there is no relation between 25(OH)D and adiponectin levels. In 
obese children, There are significant negative correlations between 25(OH)D with lipid profile, and 
between adiponectin levels with blood pressure. 
 
 
 
 
 
Introduction 
 
Obesity is one of the most serious public 
health problems in the 21
st
 century [1]. Childhood 
obesity has been known to be associated with a range 
of health problems, which may last until adult life and 
cause premature morbidity and mortality [2]. Evidence 
is accumulating to suggest that there is a potential link 
between obesity and Vitamin D deficiency among 
global populations [3]. Vitamin D (1,25-
dihydroxycholecalciferol; Calcitriol) is essential for 
normal growth and development. Recent studies have 
suggested that vitamin D deficiency is associated with 
cardiometabolic risk factors, autoimmune diseases, 
insulin resistance, abnormal lipid profile, and high 
blood pressure (BP) in adults [4]. However, few 
studies have evaluated the relationship between 
25(OH)D concentrations and the cardiometabolic risk 
factors in children and adolescents, first  was  Reis et 
al., [5] from USA and the last research from Italy was 
Walker et al., [6].  
Adiponectin is also emerging as an important 
mediator of risk for cardiovascular disease [7]. 
Clinically, hypoadiponectinemia is associated with 
both obesity and cardiovascular disease, whereas 
high serum adiponectin levels correlate with improved 
cardiovascular function and atherosclerosis [8]. Many 
researchers have observed decreasing adiponectin 
levels in association with increased obesity in children 
[9, 10].  
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Kardas and his colleagues [11], suggested 
that the interaction between vitamin D and adiponectin 
levels may be an indicator of cardiometabolic risk 
factors such as atherosclerosis. Studies regarding the 
association between vitamin D and adiponectin levels 
with cardiometabolic risk factors in obese and healthy 
children are few. 
So, the purpose of this research is to evaluate 
the association between cardio metabolic risk factors 
with both adiponectin and 25(OH)D levels and that 
between adiponectin and 25(OH)D levels among 
obese Egyptian children. 
 
Subjects and Methods 
 
This case-control cross sectional study 
consisted of 65 obese children (32 males and 33 
females), and 30 control non-obese ones (15 males 
and 15 females) with age range 8-11 years. They 
were derived from a cross-sectional survey, 
conducted on 2083 child (874 boys and 1209 girls), 
from 2 primary public schools, randomly selected, 
situated in Giza governorate, Egypt. Pupils were 
excluded if they had a prior major illness, including 
type 1 or 2 diabetes, received medications or had a 
condition known to influence their physical growth.  
Prior to enrollment, permission to perform the 
study was granted by the Ministry of Education, and 
the directors of the schools included in the research. 
Parents were fully informed about the purpose and 
methods of the study and signed a written consent. 
The children provided their verbal assent. Approval to 
conduct this survey was granted by the "Ethical 
Committee" of the “National Research Centre”. All 
information and blood samples were collected by a 
well-trained staff during morning visits to the schools. 
The study sample was divided into 2 groups 
(obese and non-obese) by body mass index (BMI) 
(kg/m
2
), which was percentile-specific for sex and age 
of Egyptian children and adolescents [12]. Healthy, 
age- and sex-matched children were selected as 
control. The BMI of the obese children was greater 
than the 95
th
 percentile for age and sex, while the BMI 
of the control children ranged between 15
th
 and 85
th
 
percentiles based on the Egyptian Growth Reference 
Charts [12].  
 
Anthropometric assessment 
Each child underwent a complete physical 
examination. Then, anthropometric measurements 
including weight in kilograms (kg) and height in 
centimeters (cm); for each child; were performed by 
the same trained doctor using standard devices and 
following the recommendations of the International 
Biological program [13]. Height was measured to the 
nearest 0.1 cm on a Holtain portable anthropometer, 
and weight was determined to the nearest 0.01 kg 
using Seca Scale Balance, with the subject wearing 
minimal clothing and no shoes. BMI; as weight (kg) 
divided by height (m)
2 
; was calculated. Systolic blood 
pressure (SBP) and diastolic blood pressure (DBP) 
were measured twice using a mercury 
sphygmomanometer, after the subject rested for at 
least 20 min. 
 
Biological Parameters 
Early morning forearm venous blood samples 
(5 ml) were obtained from each child; before 
breakfast; for biochemical screening tests after 12-
hours overnight fasting. Professional staff performed 
venipuncture. The blood samples were left to clot; 
sera were separated by centrifugation for 10 minutes 
at 5000 rpm then stored at -80ºC until assays. Plasma 
25(OH) D levels were measured by high-pressure 
liquid chromatography (HPLC) using Clin- Rep kits 
(IRIS Technologies International GmbH, Cursdorf, 
Germany). Serum adiponectin levels were measured 
using commercially available Enzyme Linked 
Immunosorbent Assay (ELISA) kits, provided by 
AviBion Orgenium Laboratories, Finland. Serum 
concentrations of total cholesterol (TC: normal range, 
160–200 mg/dL), triglycerides (TG: normal range, 40–
140 mg/dL) and high-density lipoprotein-cholesterol 
(HDL-C: normal range, 35–80 mg/dL) were measured 
using commercially available kits provided by 
STANBIO Laboratory Inc. (1261 North Main Street 
Boerne Texas 78006 USA).  
LDL-C (normal range, 100–130 mg/dL) was 
calculated according to an equation developed by 
Friedewald et al. [14], as follows:  
LDL-C= Total cholesterol –Triglycerides/5+ HDL-C. 
  
Statistical Analysis 
Data analysis was performed using SPSS 
version 16.0 (SPSS. Inc., Chicago, IL, USA). The 
results were expressed as mean ± SD. The 
Kolmogorov-Smirnov test was used to determine the 
normality of the data, and revealed that it was not 
normally distributed. Differences between groups 
were analyzed using the Mann-Whitney test. 
Spearmanۥ s correlation coefficients were used to 
assess relationships between independent variables. 
The level of significance was set at a probability of 
less than 5% (p < 0.05). 
 
Results 
 
The mean 25(OH)D levels in the total sample, 
males and females were 33.02 ± 11.97, 35.71 ± 
10.61, and 30.89 ± 12.64 ng/mL respectively. There 
was significant sex difference in 25(OH)D levels in the 
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control group only; where males had the higher 
values; while insignificant sex difference was recorded 
between the obese group and total sample. However, 
insignificant sex difference in adiponectin level was 
recorded between the total sample and both groups 
(Table 1). Moreover, insignificant sex difference in the 
blood pressure and lipid profile was found in obese 
and control groups. So, the analysis was completed 
without sex differentiation.  
Table 1: Sex differences in 25-hydroxy Vitamin D and 
adiponectin levels in obese and control.  
 Total  Males  Females  
Z-value P 
 Mean +SD Mean +SD Mean +SD 
Obese (N= 
65): 
        
25-hydroxy 
Vit D (ng/ml) 
29.93 +10.34 32.00 +7.69 27.92 +12.17 - 1.734 0.083 
Adiponectin 
(µg/ml) 
1.76 +0.43 1.80 +0.45 1.71 +0.409 - 0.881 0.378 
         
Control 
(N=30): 
        
25-hydroxy 
Vit D (ng/ml) 
39.73 +12.67 47.60 +10.15 35.80 +12.13 - 2.313 0.019* 
Adiponectin 
(µg/ml) 
4.01 + 0.83 3.99 + 0.83 4.02 + 0.87 -0.145 0.902 
         
Total (N=95):         
25-hydroxy 
Vit D (ng/ml) 
33.02 +11.97 35.71 +10.61 30.89 +12.64 - 1.923 0.055 
Adiponectin 
(µg/ml) 
2.47 +1.20 2.51 +1.19 2.43 +1.23 - 0.529 0.597 
*,  P<0.05 = Significant differences. 
 
Comparisons between the descriptive 
characteristics of obese and control groups of the 
study sample (clinical and biological parameters) are 
shown in Table 2. The mean ages of the study 
population, obese group, and control group were 9.99 
± 1.14, 10.1 ± 1.18 and 10.27 ± 0.74 years, 
respectively with insignificant differences. While SBP, 
DBP, TG and TC were significantly higher in the 
obese group than those in control group (  < 0.01), 
whereas LDL-C level showed insignificant difference 
between the two groups. On the other side, HDL-C, 
25(OH)D, adiponectin were significantly higher in the 
control group than those in obese group (  < 0.01 for 
all variables) (Table 2). 
The present study revealed insignificant 
correlation between 25(OH) D and adiponectin levels 
for the total sample and obese group (Table 3, 4). 
However, for total sample and obese children; 
25(OH)D levels showed a negative significant 
correlation with age, BMI, TG, TC and LDL-C levels 
and insignificant correlation with blood pressure - both 
systolic and diastolic, and HDL-C. While, adiponectin 
level showed negative significant correlations with 
blood pressure - both systolic and diastolic, and 
significant positive one with HDL-C, for both total 
sample and obese group.  
At the same time, adiponectin level showed a 
negative significant correlation with BMI, TG and TC 
and insignificant ones for the obese group. This 
means that there is significant negative relation 
between adiponectin level with BMI and lipid profile up 
to certain level. When obesity occurs (BMI>95
th
 
percentile), these relations disappear; i.e. the changes 
in adiponectin level becomes not related to the 
changes in either BMI or lipid profile (TG, TC and 
LDL) (Table 3, 4). 
 
Discussion 
 
Recent studies suggested association of 
obesity with cardiovascular diseases and both 25 
hydroxy vitamin D and adiponectin levels in children 
and adolescents [11]. Obesity is usually correlated 
with the higher prevalence of hypovitaminosis or the 
lower circulating 25(OH) D level in both pediatric as 
well as adult populations [15]. Low vitamin D stores as 
determined by 25-hydroxy vitamin D [25(OH) D] 
levels; which is the most accurate way to measure 
how much vitamin D is in the body ( normal, 
insufficiency or deficiency); are associated with 
increased risk for cardiovascular and mortality, but the 
mechanisms for this are unclear [16]. 
The prevalence of 25(OH)D deficiency was 
higher in the obese group (29.9 ng/mL) than in the 
control group (39.7 ng/mL) in the present study. In 
India, Shivaprakash and Joseph [17] also reported 
deficiency of 25(OH) D levels among 35obese 
children (17.49 ng/mL). This indicated the high 
prevalence of vitamin D insufficiency/ deficiency in the 
countries that receive abundant sunshine like India 
and Egypt. Even among American children, Johnson 
et al., [18], found that the mean level for 25(OH)D was 
28.8 ng/mL in 197 obese children. Cheng et al., [19], 
also stated that both subcutaneous and visceral 
adiposity are associated with low 25(OH) D 
concentrations. The inverse relationship between 
obesity and serum 25(OH) D concentrations may 
have several explanations, including deposition of 
vitamin D in body fat compartments, reduced release 
of vitamin D into systemic circulation and low 
exposure to sun light [20]. Until now, data regarding 
the role of vitamin D in obesity are inconclusive [21].
 
Table 2: Comparisons of BMI, blood pressure and lipid profile between obese and control.  
 Total 
(N=95 ) 
Obese 
(N= 65) 
Control 
(N=30) 
Z-value P 
 Mean +SD Mean +SD Mean +SD   
Age (years) 9.99 +1.14 10.10 +1.18  10.27 +0.74 - 0.658 0.510 
BMI (Kg/m
2) 
24.28 +5.95 27.90 +2.928 16.44 +1.67 7.809 0.000** 
SBP (mmHg) 110.88 +12.66 112.83 +14.618 106.67 +4.61 2.880 0.004* 
DBP (mmHg) 70.58 +11.53 72.69 +13.178 66.00 +4.03 4.207 0.000** 
TG (mg/dL) ) 119.98 +41.29 133.22 +34.398 91.28 +40.88 5.362 0.000** 
TC (mg/dL) 172.25 +57.45 188.72 +60.53 136.57 +26.24 4.205 0.000** 
HDL-c (mg/dL) 33.94 +17.43 21.27 + 4.88 39.87 +8.04 -5.162 0.000** 
LDL-c (mg/dL) 126.47 +53.15 133.91 + 4.95 122.99 +56.58 0.933 0.351 
25-hydroxy Vit D (ng/ml) 33.02 +11.97 29.93 +10.34 39.73 +12.66 - 3.372 0.001** 
Adiponectin (µg/ml) 2.47 +1.20 1.76 + 0.43 4.01 + 0.83 -7.812 0.000** 
*, P<0.05 = Significant differences; **, P<0.001 = highly significant differences. 
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Statistically significant inverse association of 
serum 25(OH) D with BMI and age without sex 
difference was detected in this study. This result has 
been found to be similar to Kardas and his colleagues, 
[11] in Turkey.  Abu Shady et al., [24], also found 
inverse association of serum 25(OH) D with BMI 
among 215 Egyptian school children, but with 
insignificant relation with age and sex. On contrary, 
Shivaprakash and, Joseph [17] in India and Johnson 
et al., [18] in America found insignificant relation 
between 25(OH) D levels and either BMI, age or sex. 
Table 3: Spearmanۥs correlations between 25-hydroxy Vit D, 
adiponectin and cardiometabolic risk factors among total 
sample. 
 25-hydroxy Vit D) Adiponectin 
        R    p       r     p 
Age (years) - 0.296 0.004* - 0.110 0.290 
BMI (Kg/m
2) 
- 0.260 0.036 - 0.587 0.000** 
SBP (mmHg) 0.187 0.136 - 0.434 0.000** 
DBP (mmHg) 0.006 0.963 - 0.500 0.000** 
TG (mg/dL) ) - 0.288 0.020* - 0.389 0.000** 
TC (mg/dL) - 0.413 0.001** - 0.325 0.001** 
HDL-c (mg/dL) 0.234 0.062 0.267 0.009* 
LDL-c (mg/dL) - 0.265 0.034* 0.048 0.643 
25-hydroxy Vit D (ng/ml)   - 0.202 0.107 
Adiponectin (µg/ml) - 0.202 0.107   
*, P<0.05 = Significant differences; **, P<0.001 = highly significant differences. 
 
Current results showed that adiponectin was 
lower in obese children than control. Epidemiological 
evidence supports a protective role for adiponectin in 
cardiovascular disease. Low serum adiponectin is 
also predictive of a future coronary artery ischemic 
event and the development of hypertension and the 
levels of the adipokine correlate with left ventricular 
hypertrophy. High serum adiponectin is associated 
with better recovery of cardiac function post-injury 
[22].  
Table 4: Correlation between 25-hydroxy Vit D, adiponectin and 
cardiometabolic risk factors among obese children. 
 25-hydroxy Vit D Adiponectin 
         R     p            r    p 
Age (years) - 0.410 0.001** 0.237 0.058 
BMI (Kg/m
2) 
- 0.260 0.036* 0.185 0.140 
SBP (mmHg) 0.187 0.136 - 0.346 0.005* 
DBP (mmHg) 0.006 0.963 - 0.313 0.011 
TG (mg/dL) ) - 0.288 0.020* 0.154 0.220 
TC (mg/dL) - 0.413 0.001** 0.067 0.594 
HDL-c (mg/dL) 0.234 0.062 0.359 0.004* 
LDL-c (mg/dL) - 0.265 0.034* -0.091 0.475 
25-hydroxy Vit D (ng/ml)   - 0.202 0.107 
Adiponectin (µg/ml) - 0.202 0.107   
*, P<0.05 = Significant differences; **, P<0.01 = highly significant differences. 
 
 
Moreover, the present study revealed that 
lipid profile and blood pressure were significantly 
higher in obese children as compared to control. This 
profile predisposes obese children to cardiovascular 
disease later in life as mentioned before in different 
studies [17, 23]. 
Several reports are available about the 
association between 25(OH) D and plasma lipids. In 
this study, statistically significant inverse correlation 
was identified between 25(OH) D levels and the lipid 
profile except HDL level .This result agree with that of 
Abu Shady et al., [24]. On the other hand, Dolinsky et 
al., [25], found insignificant association between 
25(OH)D level and triglycerides, total cholesterol, LDL 
or HDL. While Kardas and his colleagues, [11] found 
that 25(OH) D levels were positively correlated with  
HDL, LDL, total cholesterol, triglyceride (TG), systolic 
blood pressure (SBP), and diastolic blood pressure 
(DBP).  In theory, 25(OH) D could affect lipid profile 
directly as it is essential for maintaining adequate 
levels of apolipoprotein. In addition, the indirect effects 
of 25(OH) D on lipid profile could be through 
parathyroid hormones (PTH) or calcium balance [26].  
Current results provided the finding that 
25(OH)D is not associated with  adiponectin. This 
result agreed  with Walker et al., [6] in  Italy. In 
contrast, some recent studies have suggested that 
25(OH)D may play a role in the regulation of 
adiponectin [11, 15]. Adiponectin was identified and 
confirmed to be significantly decreased in 25(OH)D 
deficient obese pediatric [16].  Kardas et al., 2013 [11] 
in Turkey reported that 25(OH)D was positively 
correlated with adiponectin. 
Adiponectin level significantly correlates 
negatively with blood pressure parameters, both 
systolic and diastolic, among both total and obese 
children in the present study. This finding confirms the 
results of Brambilla et al., [27] in their study on 186 
obese Italian children ranging in age from 5–18 years. 
On the other hand, Li et al., [28] stated that, this 
association remains inconclusive because obese 
subjects may have different mechanisms to regulate 
blood pressure. They also, recommended that larger 
studies are needed to examine the relationship 
between adiponectin and mechanisms of blood 
pressure regulation.  
The present results showed that adiponectin 
was associated with significant positive correlation 
with HDL-C. In agreement with these findings, 
Tamang et al., [29] reported that serum adiponectin 
correlates positively with HDL-C levels in obese 
subjects. They suggested that the possible 
mechanisms may partially be explained with the 
activated receptor, which affects the genes, 
associated with HDL metabolism. Adiponectin 
stimulated ligand activates in liver and skeletal 
muscles, which results in the increased synthesis of 
HDL-C.  
This study has some important differences as 
compared with those previously discussed; that there 
is significant negative relation between adiponectin 
level and BMI up to certain level of BMI. When obesity 
occurs (BMI>95
th
 percentile), these relations 
disappear; i.e. the changes in adiponectin level 
becomes not related to the changes in BMI. This 
means that in obese children, the increase in their 
BMI is not associated with further decrease in 
adiponectin level. 
In conclusion, early detection of these risk 
factors (especially 25(OH)D and adiponectin) in 
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children can prevent the increasing risk of 
cardiovascular diseases. 
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